These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31370935)

  • 1. Protocols for the generation of caged guideRNAs for light-triggered RNA-targeting with SNAP-ADARs.
    Hanswillemenke A; Stafforst T
    Methods Enzymol; 2019; 624():47-68. PubMed ID: 31370935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current strategies for Site-Directed RNA Editing using ADARs.
    Montiel-Gonzalez MF; Diaz Quiroz JF; Rosenthal JJC
    Methods; 2019 Mar; 156():16-24. PubMed ID: 30502398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA gene editing in the eye and beyond: The neglected tool of the gene editing armatorium?
    Han RC; MacLaren RE
    Int Rev Cell Mol Biol; 2022; 372():175-205. PubMed ID: 36064264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-Directed Genome Editing of Cultured Cells.
    Yang L; Yang JL; Byrne S; Pan J; Church GM
    Curr Protoc Mol Biol; 2014 Jul; 107():31.1.1-31.1.17. PubMed ID: 24984853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.
    Ramakrishna S; Kwaku Dad AB; Beloor J; Gopalappa R; Lee SK; Kim H
    Genome Res; 2014 Jun; 24(6):1020-7. PubMed ID: 24696462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9-mediated genome editing and guide RNA design.
    Wiles MV; Qin W; Cheng AW; Wang H
    Mamm Genome; 2015 Oct; 26(9-10):501-10. PubMed ID: 25991564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing.
    Marina RJ; Brannan KW; Dong KD; Yee BA; Yeo GW
    Cell Rep; 2020 Nov; 33(5):108350. PubMed ID: 33147453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR mediated genome editing, a tool to dissect RNA modification processes.
    Pickerill ES; Bernstein DA
    Methods Enzymol; 2021; 658():435-452. PubMed ID: 34517958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering.
    Ui-Tei K; Maruyama S; Nakano Y
    Genome; 2017 Jun; 60(6):537-545. PubMed ID: 28177825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatiotemporal Control of CRISPR/Cas9 Function in Cells and Zebrafish using Light-Activated Guide RNA.
    Zhou W; Brown W; Bardhan A; Delaney M; Ilk AS; Rauen RR; Kahn SI; Tsang M; Deiters A
    Angew Chem Int Ed Engl; 2020 Jun; 59(23):8998-9003. PubMed ID: 32160370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-Directed RNA Editing in Vivo Can Be Triggered by the Light-Driven Assembly of an Artificial Riboprotein.
    Hanswillemenke A; Kuzdere T; Vogel P; Jékely G; Stafforst T
    J Am Chem Soc; 2015 Dec; 137(50):15875-81. PubMed ID: 26594902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM.
    Tang LC; Gu F
    Yi Chuan; 2020 Mar; 42(3):236-249. PubMed ID: 32217510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light-triggered site-directed RNA editing by endogenous ADAR1 with photolabile guide RNA.
    Zhang Y; Feng D; Mu G; Wang Q; Wang J; Luo Y; Tang X
    Cell Chem Biol; 2023 Jun; ():. PubMed ID: 37295425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qPCR method for genome editing efficiency determination and single-cell clone screening in human cells.
    Li B; Ren N; Yang L; Liu J; Huang Q
    Sci Rep; 2019 Dec; 9(1):18877. PubMed ID: 31827197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion.
    Krohannon A; Srivastava M; Rauch S; Srivastava R; Dickinson BC; Janga SC
    BMC Genomics; 2022 Mar; 23(1):172. PubMed ID: 35236300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
    Liu GG; Li S; Wei YD; Zhang YX; Ding QR
    Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
    Liu L; Pei DS
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The next generation of CRISPR-Cas technologies and applications.
    Pickar-Oliver A; Gersbach CA
    Nat Rev Mol Cell Biol; 2019 Aug; 20(8):490-507. PubMed ID: 31147612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.